These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 38414054)

  • 1. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
    Ma YY; Li X; Yu JT; Wang YJ
    Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
    Fang P; Kazmi SA; Jameson KG; Hsiao EY
    Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
    J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases.
    Zhu X; Li B; Lou P; Dai T; Chen Y; Zhuge A; Yuan Y; Li L
    Neurosci Bull; 2021 Oct; 37(10):1510-1522. PubMed ID: 34216356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.
    Raval U; Harary JM; Zeng E; Pasinetti GM
    Expert Rev Neurother; 2020 Jul; 20(7):673-686. PubMed ID: 32459513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review.
    Yadav H; Jaldhi ; Bhardwaj R; Anamika ; Bakshi A; Gupta S; Maurya SK
    Life Sci; 2023 Oct; 330():122022. PubMed ID: 37579835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
    Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
    Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review.
    Mincic AM; Antal M; Filip L; Miere D
    Clin Nutr; 2024 Jul; 43(7):1832-1849. PubMed ID: 38878554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
    Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
    Moțățăianu A; Șerban G; Andone S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
    Yang J; Li H; Zhao Y
    Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.